Nature asked eight synthetic-biology experts about the implications for science and society of the “synthetic cell” made by the J. Craig Venter Institute (JCVI). The institute's team assembled, modified and implanted a synthesized genome into a DNA-free bacterial shell to make a self-replicating Mycoplasma mycoides.
This is a preview of subscription content
Access options
Subscribe to Journal
Get full journal access for 1 year
$199.00
only $3.90 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Buy article
Get time limited or full article access on ReadCube.
$32.00
All prices are NET prices.
Additional information
See Editorial, page 397 .
Rights and permissions
About this article
Cite this article
Life after the synthetic cell. Nature 465, 422–424 (2010). https://doi.org/10.1038/465422a
Published:
Issue Date:
DOI: https://doi.org/10.1038/465422a
Further reading
-
The Diversity of Engineering in Synthetic Biology
NanoEthics (2020)
-
From Buzz to Burst—Critical Remarks on the Term ‘Life’ and Its Ethical Implications in Synthetic Biology
NanoEthics (2019)
-
Rethinking risk assessment for emerging technology first-in-human trials
Medicine, Health Care and Philosophy (2016)
-
Different Understandings of Life as an Opportunity to Enrich the Debate About Synthetic Biology
NanoEthics (2015)
-
Artificial Life and Ethics
NanoEthics (2014)
